Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Sun Loo, Andrew W Roberts, Natasha S Anstee, Glen A Kennedy, Simon He, Anthony P Schwarer, Anoop K Enjeti, James D'Rozario, Paula Marlton, Ian A Bilmon, John Taper, Gavin Cull, Campbell Tiley, Emma Verner, Uwe Hahn, Devendra K Hiwase, Harry J Iland, Nick Murphy, Sundra Ramanathan, John Reynolds, Doen Ming Ong, Ing Soo Tiong, Meaghan Wall, Michael Murray, Tristan Rawling, Joanna Leadbetter, Leesa Rowley, Maya Latimer, Sam Yuen, Stephen B Ting, Chun Yew Fong, Kirk Morris, Ashish Bajel, John F Seymour, Mark J Levis, Andrew H Wei
Blood 2023;142(23):1960-1971